The Swiss Innovation Hub for Precision Medicine

Thomas Brenzikofer
Thomas Brenzikofer

Director DayOne Initiative, Senior Project Manager ICT, Public Relations

22.10.2018

DayOne Experts «Digital Biomarkers – Paradigm shift or pie in the sky?»

Digital biomarkers are objective, quantifiable, physiological and behavioral data that are collected and measured by means of digital devices. Their use and evaluation is growing rapidly. Experts estimate that by 2025 70 percent of all clinical trials will include digital biomarkers to explain and predict health outcomes. It is also expected that digital Biomarkers, capturing clinically meaningful and objective data by continuously monitoring patients and healthy individuals, will open a complete new field to a better understanding of the progression and the management of diseases. It is therefore not surprising that digital biomarkers are getting increasing attention from the pharma industry, academia and forward thinking health care professionals.
 
Our next DayOne Expert Event will be a deep dive into current applications of digital biomarkers and debate how digital devices such as portables, wearables, implantations or digestibles will shape the future of health.
 
When: October 22, starting from 6 pm
Where: University Hospital Basel, Zentrum für Lehre und Forschung, Hebelstrasse 20
 
Program

18:00

Doors open

18:30

Welcome

18:40

Introduction
by Jörg Goldhahn, ETH

19:00

Short presentations and Panel Discussion with
Emilio Merlo-Pich, Takeda; Clay Ieuan, Novartis; Jens Eckstein, University Hospital Basel; Jörg Goldhahn, ETHZ; Florian Lipsmeier, Lead Digital Biomarker Data Analysis, Roche

19:45

Apero & Networking

 
Participation to the event is free of charge; however, your registration is mandatory.
 

> Back to overview
Future of health Fertile Growth /dam/jcr:157e4b39-6a0b-48d4-99ba-1ec88f5c5aeb/day_gra_dayone_partners.svg Initiative by BaselArea.swiss